The Latest in Leukemia, Myelodysplasia, Transplantation

Application for pegfilgrastim biosimilar withdrawn

September 17, 2017

CHMP recommends approval of nilotinib for kids

September 16, 2017

Immune status linked to outcomes of CAR T-cell therapy

September 15, 2017

Survey reveals lack of specialized care for AYAs with cancer

September 15, 2017

Report details progress, obstacles in cancer research and care

September 14, 2017

FDA grants priority review for drug to treat APL

September 14, 2017

Treatment for WDTC tied to increased risk of AML

September 12, 2017

Study: Many cancer patients don’t understand clinical trials

September 11, 2017

CCSs have higher burden of chronic conditions

September 9, 2017

Studies of donor CAR T cells placed on hold

September 6, 2017

FDA grants orphan designation to product for CMV

September 6, 2017

FDA grants orphan designation to product for GVHD

September 6, 2017

Withdrawn AML drug back on market in US

September 2, 2017

Nanocarriers could treat leukemia, lymphoma and improve HSCT

September 1, 2017

Young cancer patients want more digital support, survey says

September 1, 2017